Literature DB >> 16736726

Triphasic waves versus nonconvulsive status epilepticus: EEG distinction.

Jean-Martin Boulanger1, Charles Deacon, Diane Lécuyer, Sylvie Gosselin, Jean Reiher.   

Abstract

BACKGROUND: Triphasic waves (TWs) and generalized nonconvulsive status epilepticus (GNCSE) share morphological features that may create diagnostic ambiguity.
OBJECTIVE: To describe electroencephalographic differences between TWs and GNCSE.
METHODS: We retrospectively compared the electroencephalograms (EEGs) of two groups of patients presenting with decreased level of consciousness; those with TWs associated with metabolic encephalopathy and those with GNCSE. We studied the following: demographics, etiology and EEG morphological features. All EEGs were classified blindly (TWs or GNCSE) by two expert EEGers. Agreement between experts and concordance with clinical diagnosis were measured.
RESULTS: We analysed 87 EEGs (71 patients) with TWs and 27 EEGs (13 patients) with GNCSE. Agreement between experts and concordance with clinical diagnosis were excellent. When compared to TWs, epileptiform discharges associated with GNCSE had a higher frequency (mean=2.4Hz vs 1.8Hz) (p<0.001), a shorter duration of phase one (p=0.001), extra-spikes components (69% vs 0%) (p<0.001) and less generalized background slowing (15.1% vs 91.1%) (p<0.001). Amplitude predominance of phase two was common with TWs (40.8% vs 0%) (p=0.01). Lag of phase two was absent in all cases of GNCSE but present in 40.8% of patients with TWs. Noxious or auditory stimulation frequently increased the TWs (51%) while it had no effect on the epileptiform pattern (p=0.008).
CONCLUSIONS: Certain EEG morphological criteria and the response to stimulation are very helpful in distinguishing TWs from GNCSE.

Entities:  

Mesh:

Year:  2006        PMID: 16736726     DOI: 10.1017/s0317167100004935

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  8 in total

Review 1.  The standardization debate: A conflation trap in critical care electroencephalography.

Authors:  Marcus C Ng; Nicolas Gaspard; Andrew J Cole; Daniel B Hoch; Sydney S Cash; Matt Bianchi; Deirdre A O'Rourke; Eric S Rosenthal; Catherine J Chu; M Brandon Westover
Journal:  Seizure       Date:  2014-10-16       Impact factor: 3.184

2.  Response Rates to Anticonvulsant Trials in Patients with Triphasic-Wave EEG Patterns of Uncertain Significance.

Authors:  Deirdre O'Rourke; Patrick M Chen; Nicolas Gaspard; Brandon Foreman; Lauren McClain; Ioannis Karakis; Advait Mahulikar; M Brandon Westover
Journal:  Neurocrit Care       Date:  2016-04       Impact factor: 3.210

3.  Power spectrum analysis and outcomes of non-convulsive status epilepticus: a single-center study.

Authors:  Jianhua Chen; Liri Jin; Xiangqin Zhou; Qiang Lu; Qing Liu; Yan Huang
Journal:  Neurol Sci       Date:  2022-09-30       Impact factor: 3.830

4.  Detecting abnormal electroencephalograms using deep convolutional networks.

Authors:  K G van Leeuwen; H Sun; M Tabaeizadeh; A F Struck; M J A M van Putten; M B Westover
Journal:  Clin Neurophysiol       Date:  2018-11-17       Impact factor: 3.708

5.  Electroencephalography and delirium in the postoperative period.

Authors:  B J A Palanca; T S Wildes; Y S Ju; S Ching; M S Avidan
Journal:  Br J Anaesth       Date:  2017-08-01       Impact factor: 9.166

6.  Creutzfeldt-Jakob Disease Presenting as Nonconvulsive Status Epilepticus.

Authors:  Aleksei Rakitin; Riina Vibo; Vaiko Veikat; Anne Õunapuu; Aive Liigant; Sulev Haldre
Journal:  Case Rep Neurol Med       Date:  2018-11-04

7.  Do Triphasic Waves and Nonconvulsive Status Epilepticus Arise From Similar Mechanisms? A Computational Model.

Authors:  Sophie Ligtenstein; Jiangling Song; Jin Jin; Haoqi Sun; Luis Paixao; Sahar Zafar; M Brandon Westover
Journal:  J Clin Neurophysiol       Date:  2021-09-01       Impact factor: 2.590

Review 8.  [S2k guidelines: status epilepticus in adulthood : Guidelines of the German Society for Neurology].

Authors:  F Rosenow; J Weber
Journal:  Nervenarzt       Date:  2021-03-22       Impact factor: 1.214

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.